Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of raloxifene -- a selective oestrogen receptor modulator -- on kidney function in post-menopausal women with Type 2 diabetes: results from a randomized, placebo-controlled pilot trial.
Hadjadj S, Gourdy P, Zaoui P, Guerci B, Roudaut N, Gautier JF, Chabin M, Mauco G, Ragot S; RADIAN Study Group. Hadjadj S, et al. Among authors: guerci b. Diabet Med. 2007 Aug;24(8):906-10. doi: 10.1111/j.1464-5491.2007.02165.x. Epub 2007 Apr 19. Diabet Med. 2007. PMID: 17451421 Clinical Trial.
Sex hormone levels are not associated with progression of renal disease in male patients with T2DM.
Feigerlová E, Saulnier PJ, Gourdy P, Roussel R, Halimi JM, Gand E, Dardari D, Guerci B, Sosner P, Marre M, Zaoui P, Ragot S, Hadjadj S; DIAB 2 NEPHROGENE, SURDIAGENE Study Groups. Feigerlová E, et al. Among authors: guerci b. Diabetes Metab. 2017 Apr;43(2):140-145. doi: 10.1016/j.diabet.2016.05.012. Epub 2016 Jun 22. Diabetes Metab. 2017. PMID: 27344412
Urinary lysophopholipids are increased in diabetic patients with nephropathy.
Saulnier-Blache JS, Feigerlova E, Halimi JM, Gourdy P, Roussel R, Guerci B, Dupuy A, Bertrand-Michel J, Bascands JL, Hadjadj S, Schanstra JP. Saulnier-Blache JS, et al. Among authors: guerci b. J Diabetes Complications. 2017 Jul;31(7):1103-1108. doi: 10.1016/j.jdiacomp.2017.04.024. Epub 2017 May 10. J Diabetes Complications. 2017. PMID: 28506691
Practical implementation, education and interpretation guidelines for continuous glucose monitoring: A French position statement.
Borot S, Benhamou PY, Atlan C, Bismuth E, Bonnemaison E, Catargi B, Charpentier G, Farret A, Filhol N, Franc S, Gouet D, Guerci B, Guilhem I, Guillot C, Jeandidier N, Joubert M, Melki V, Merlen E, Penfornis A, Picard S, Renard E, Reznik Y, Riveline JP, Rudoni S, Schaepelynck P, Sola-Gazagnes A, Tubiana-Rufi N, Verier-Mine O, Hanaire H; Société francophone du diabète (SFD), Société française d’endocrinologie (SFE); Évaluation dans le diabète des implants actifs Group (EVADIAC). Borot S, et al. Among authors: guerci b. Diabetes Metab. 2018 Feb;44(1):61-72. doi: 10.1016/j.diabet.2017.10.009. Epub 2017 Nov 11. Diabetes Metab. 2018. PMID: 29174479
[Management of dyslipidemia in adult].
Béliard S, Bonnet F, Bouhanick B, Charrière S, Cariou B, Durlach V, Moulin P, Valéro R, Vergès B, Boccara F, Farnier M, Feve B, Gourdy P, Guerci B, Krempf M, Moulin P. Béliard S, et al. Among authors: guerci b. Rev Prat. 2016 Sep;66(7):727-41. Rev Prat. 2016. PMID: 30512287 French. No abstract available.
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Nowack C, Kolkhof P, Ferreira AC, Schloemer P, Filippatos G; on behalf of the FIDELIO-DKD study investigators; FIDELIO-DKD study investigators. Bakris GL, et al. Am J Nephrol. 2019;50(5):333-344. doi: 10.1159/000503713. Epub 2019 Oct 25. Am J Nephrol. 2019. PMID: 31655812 Free PMC article. Clinical Trial.
223 results